Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Gross

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Wurzburger Medizinhistorische Mitteilungen|January 1, 1993
[Not Available]H M Gross, G Keil
The American Journal of Medicine|April 1, 1984
Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancerJ C Chang, H M Gross
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Neoplastic fever responds to the treatment of an adequate dose of naproxenJ C Chang, H M Gross
The American Journal of the Medical Sciences|May 1, 1988
Remission of chronic idiopathic myelofibrosis to busulfan treatmentJ C Chang, H M Gross
AJR. American Journal of Roentgenology|May 1, 1989
Acute thrombocytopenia after i.v. administration of a radiographic contrast mediumJ C Chang, D Lee, H M Gross
The American Journal of the Medical Sciences|November 1, 1990
Disseminated intravascular coagulation due to intravenous administration of hetastarchJ C Chang, H M Gross, N S Jang
Neural Networks : the Official Journal of the International Neural Network Society|March 29, 2003
Generative character of perception: a neural architecture for sensorimotor anticipationH -M. Gross, A Heinze, T Seiler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end pointE J Small, D Lew, B G Redman, et al.
Journal of the National Cancer Institute|March 3, 1993
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancerW K Murphy, F V Fossella, R J Winn, et al.
Cancer|November 15, 1995
Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancerD V Jones, R J Winn, B W Brown, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Wurzburger Medizinhistorische Mitteilungen|January 1, 1993
[Not Available]H M Gross, G Keil
The American Journal of Medicine|April 1, 1984
Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancerJ C Chang, H M Gross
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Neoplastic fever responds to the treatment of an adequate dose of naproxenJ C Chang, H M Gross
The American Journal of the Medical Sciences|May 1, 1988
Remission of chronic idiopathic myelofibrosis to busulfan treatmentJ C Chang, H M Gross
AJR. American Journal of Roentgenology|May 1, 1989
Acute thrombocytopenia after i.v. administration of a radiographic contrast mediumJ C Chang, D Lee, H M Gross
The American Journal of the Medical Sciences|November 1, 1990
Disseminated intravascular coagulation due to intravenous administration of hetastarchJ C Chang, H M Gross, N S Jang
Neural Networks : the Official Journal of the International Neural Network Society|March 29, 2003
Generative character of perception: a neural architecture for sensorimotor anticipationH -M. Gross, A Heinze, T Seiler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end pointE J Small, D Lew, B G Redman, et al.
Journal of the National Cancer Institute|March 3, 1993
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancerW K Murphy, F V Fossella, R J Winn, et al.
Cancer|November 15, 1995
Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancerD V Jones, R J Winn, B W Brown, et al.
Pageof 2